MHX 2026, one of Asia's premier healthcare exhibitions, was held in Bangkok, Thailand, bringing together leading medical device manufacturers, healthcare professionals, distributors, and industry experts from around the world. As a key platform connecting the Asian healthcare industry with the global market, the exhibition highlighted the latest medical innovations while fostering international collaboration and industry development.

Hunan Endovascular Medical Device Co., Ltd. (EVT Medical) showcased its comprehensive portfolio of non-vascular minimally invasive interventional products, demonstrating the company's technological expertise, diversified product portfolio, and professional clinical solutions. Through the exhibition, EVT Medical highlighted the innovation and manufacturing capabilities of Chinese medical device companies in minimally invasive intervention while engaging with global partners to explore new opportunities for international collaboration and sustainable industry growth.

At MHX 2026, EVT Medical presented a broad portfolio of its core products, including hydrophilic guidewires, stone retrieval baskets, ureteral access sheaths, percutaneous nephrostomy kits, and biliary drainage solutions. The company also showcased its innovative Ureteral Stent System technology, further demonstrating its strong R&D capabilities and commitment to advancing non-vascular interventional therapies. Among the highlights was EVT Medical's Ureteral Stent System, one of the earliest domestically developed and commercially launched Ureteral Stent System products in China. Representing the company's continued investment in technological innovation, the product reflects EVT Medical's commitment to driving advancements in interventional therapy and delivering high-quality minimally invasive solutions to healthcare professionals worldwide.

Throughout the exhibition, EVT Medical welcomed healthcare professionals, distributors, and industry partners from Thailand, Malaysia, Vietnam, South Korea, India, and other countries across the region. Visitors engaged in in-depth discussions on product innovation, clinical applications, regulatory pathways, and potential business partnerships. The event provided a valuable opportunity for EVT Medical to strengthen relationships with international partners, gain deeper insights into regional market needs, and further accelerate its global market expansion.

MHX 2026 marks another important milestone in EVT Medical's international growth strategy and reinforces the company's commitment to expanding its presence in Southeast Asia. Looking ahead, EVT Medical will continue to invest in innovation, product quality, and customer-focused solutions while working closely with global partners to advance minimally invasive healthcare and improve patient outcomes around the world.